AVIV vs JDVI

AVIVAAvantis International Large Cap Value ETF

JDVIDJohn Hancock Disciplined Value International Select ETF

In short

AVIV Avantis takes the academic value playbook overseas: about 600 developed-market large caps screened for cheap prices and strong profitability, at 0.25% a year. Active management without the active-manager price tag.

JDVI A concentrated take on international value: roughly 40 developed- and emerging-market stocks picked bottom-up for quality and cheapness, priced at 0.69% net of a waiver through July 31, 2027 (0.98% gross).

Stated mandate

AVIV The fund seeks long-term capital appreciation through a broadly diversified portfolio of large-capitalization companies in non-U.S. developed countries.

JDVI The fund seeks long-term capital growth through a diversified portfolio of developed- and emerging-market international stocks considered high quality and undervalued, selected through bottom-up fundamental research with disciplined valuation and risk control.

Why people hold it

• AVIV 0.25% a year, against a roughly 0.65% median across active international value funds. Cheap enough that the fee stops being the deciding factor.
• Two screens, not one: cheap valuations plus higher profitability. Both factors are written into the mandate rather than left to a manager's mood.
• About 600 large caps spread across non-US developed markets, so no single name or country steers the fund. Breadth is the design, not a byproduct.
• Among the active international value ETFs we cover, one of the strongest implementations in the group, and it has been running since 2021.

• JDVI Roughly 40 names, not a sprawling index basket. Each holding has to earn its slot through bottom-up fundamental research on quality and valuation.
• The mandate covers developed and emerging markets in one wrapper, so the manager can hunt cheap quality in Tokyo or Taipei without a bolt-on EM fund.
• A contractual waiver cuts the 0.98% gross fee to 0.69% through July 31, 2027, so today's sticker is the lower number.

Worth knowing

• AVIV Value tilts can lag the broad market for long stretches. This one holds the tilt through those stretches rather than trying to time it.
• Active, with no published index behind it. You are buying the Avantis process, not a rulebook you can audit line by line.
• Large caps only. The same approach for smaller overseas companies lives in a sibling fund, AVDV, which charges 0.36%.

• JDVI Cost sits above the category norm even after the waiver that trims 0.98% gross to 0.69% through July 31, 2027. Unwaived rivals AVIV (0.25%) and AVDV (0.36%) charge less.
• Concentration cuts both ways: with about 40 holdings, one name or one country moves this fund harder than it would a broad international index.
• Short history. Shares began trading in December 2023, so there is limited record of how the strategy behaves across a full market cycle.

Full AVIV profile⁠

Full JDVI profile⁠